Expected use
The Creatine Kinase MB One-Step Test Kit (CK-MB) is a convenient and rapid immunochromatographic assay for the detection of CK-MB at or above the 5 ng / ml limit of inhuman serum or plasma samples. It is intended for professional use as an aid in the diagnosis of acute myocardial infarction (AMI). This trial provides only a preliminary result. Clinical experience and professional judgment should be sought to further evaluate the test result.
Summary and explanation
Myocardial infarction, also known as myocardial infarction, is coronary atherosclerosis based on sustained severe acute myocardial ischemia caused in part by myocardial necrosis. Skeletal muscle cell plasma levels of <5%, making the heart-type isoenzyme. CK-MB in acute myocardial infarction when released into the blood, its 4-5 hours after the onset of symptoms to reach the upper limit of normal, 12-24 hours reached a peak in 72 hours back to the normal. CK-MB lesions of myocardial cells with a specific lesion have been confirmed, but in acute skeletal muscle it can also occur when the timing of CK-MB increase. CK-MB can present early, sensitive and has a specific diagnosis of myocardial infarction.
